연구동향 분석

Intralesional 3% Sodium Tetradecyl Sulfate for Treatment of Cutaneous Kaposi’s Sarcoma

홍승필 김지영 김지석 김명화 박병철 2015년

논문상세정보
인용/피인용
' Intralesional 3% Sodium Tetradecyl Sulfate for Treatment of Cutaneous Kaposi’s Sarcoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,576 0

0.0%

' Intralesional 3% Sodium Tetradecyl Sulfate for Treatment of Cutaneous Kaposi’s Sarcoma' 의 참고문헌

  • Update on classic Kaposi sarcoma therapy: new look at an old disease
    Di Lorenzo G Crit Rev Oncol Hematol 68 : 242 ~ 249 [2008]
  • Sclerotherapy for the treatment of nodular intraoral Kaposi’s sarcoma in patients with AIDS
    Muzyka BC N Engl J Med 328 : 210 ~ 211 [1993]
  • Kaposi’s sarcoma responding to topical imiquimod 5% cream: a case report
    Benomar S Cases J 2 : 7092 ~ [2009]
  • Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi’s sarcoma. A double blind, randomized clinical trial
    Ramírez-Amador V Oral Oncol 38 : 460 ~ 467 [2002]
  • Imiquimod 5% cream for treatment of HIV-negative Kaposi’s sarcoma skin lesions: A phase I to II, open-label trial in 17 patients
    Célestin Schartz NE J Am Acad Dermatol 58 : 585 ~ 591 [2008]